Carnitine O-Palmitoyltransferase
"Carnitine O-Palmitoyltransferase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes reversibly the conversion of palmitoyl-CoA to palmitoylcarnitine in the inner mitochondrial membrane. EC 2.3.1.21.
| Descriptor ID |
D002334
|
| MeSH Number(s) |
D08.811.913.050.350.200
|
| Concept/Terms |
Carnitine O-Palmitoyltransferase- Carnitine O-Palmitoyltransferase
- Carnitine O Palmitoyltransferase
- O-Palmitoyltransferase, Carnitine
- Palmitoylcarnitine Transferase
- Transferase, Palmitoylcarnitine
- Carnitine Palmitoyltransferase
- Palmitoyltransferase, Carnitine
- Palmitylcarnitine Acyltransferase
- Acyltransferase, Palmitylcarnitine
- Carnitine Acyltransferase I
- Acyltransferase I, Carnitine
|
Below are MeSH descriptors whose meaning is more general than "Carnitine O-Palmitoyltransferase".
Below are MeSH descriptors whose meaning is more specific than "Carnitine O-Palmitoyltransferase".
This graph shows the total number of publications written about "Carnitine O-Palmitoyltransferase" by people in this website by year, and whether "Carnitine O-Palmitoyltransferase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carnitine O-Palmitoyltransferase" by people in Profiles.
-
Targeting the hepatic circadian clock concomitant with tyrosine kinase inhibition reverses late-stage hepatocellular carcinoma. Cell Rep. 2025 Nov 25; 44(11):116313.
-
SLC44A2 negatively regulates mitochondrial fatty acid oxidation to suppress colorectal progression by blocking the MUL1-CPT2 interaction. Cell Death Dis. 2025 Jul 01; 16(1):468.
-
Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer. Cell Rep Med. 2021 12 21; 2(12):100471.
-
PHDs/CPT1B/VDAC1 axis regulates long-chain fatty acid oxidation in cardiomyocytes. Cell Rep. 2021 10 05; 37(1):109767.
-
A multi-ethnic epigenome-wide association study of leukocyte DNA methylation and blood lipids. Nat Commun. 2021 06 28; 12(1):3987.
-
Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer. BMC Cancer. 2021 Apr 15; 21(1):409.
-
Carbohydrate and fat intake associated with risk of metabolic diseases through epigenetics of CPT1A. Am J Clin Nutr. 2020 11 11; 112(5):1200-1211.
-
Statin use in carnitine palmitoyltransferase II deficiency. J Clin Lipidol. 2019 Jul - Aug; 13(4):550-553.
-
miR-142 controls metabolic reprogramming that regulates dendritic cell activation. J Clin Invest. 2019 04 08; 129(5):2029-2042.
-
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer. Clin Cancer Res. 2019 06 15; 25(12):3689-3701.